Preparation and characterization of PLGA nanospheres for the targeted delivery of NR2B-specific antisense oligonucleotides to the NMDA receptors in the brain

References

• Berton M, Allémann E, Stein CA, Gurny R. 1999. Highly loaded nanoparticulate carrier using a hydrophobic antisense oligonucleotide complex. European Journal of Pharmaceutical Sciences 9:163–175.
   PubMedGoogle Scholar
• Chavany C, Saisonbehmoaras T, Ledoan T, Puisieux F, Couvreur P, Helene C. 1994. Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake. Pharmaceutical Research 11:1370–1378.
   PubMedGoogle Scholar
• Choi DW. 1992. Excitotoxic cell death. Journal of Neurobiology 23:1261–1276.
   PubMedGoogle Scholar
• Choi DW. 1994. Glutamate receptors and the induction of excitotoxic neuronal death. Progress in Brain Research 100:47–51.
   PubMedGoogle Scholar
• Cleek RL,, Rege AA, Denner LA, Eskin SG, Mikos AG. 1997. Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide release from poly (DL-lactide-co-glycolic acid) microparticles. Journal of Biomedical Materials Research 35:525–530.
   PubMedGoogle Scholar
• De Rosa G, Quaglia F, La Rotonda MI, Appel M, Alphandary H, Fattal E. 2002. Poly(lactide-coglycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes. Journal of Pharmaceutical Sciences 91:790–799.
   PubMedGoogle Scholar
• Delie F, Berton M, Allémann E, Gurny R. 2001. Comparison of two methods of encapsulation of an oligonucleotide into poly (D,L-lactic acid) particles. International Journal of Pharmaceutics 214:25–30.
   PubMedGoogle Scholar
• Hudson AJ, Lewis KJ, Rao MV, Akhtar S. 1996. Biodegradable polymer matrices for the sustained exogenous delivery of a biologically active c-myc hammerhead ribozyme. International Journal of Pharmaceutics 136:23–29.
   Google Scholar
• Khan A, Sommer W, Fuxe K, Akhtar S. 2000. Site-specific administration of antisense oligonucleotides using biodegredable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain. Journal of Drug Targeting 8:319–334.
   PubMedGoogle Scholar
• Kwon HY, Lee JY, Choi SW, jang Y, Kim JH. 2001. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method. Physicochemical and Engineering Aspects 182:123–130.
   Google Scholar
• Lewis KJ, Irwin WJ, Akhtar S. 1995. Biodegradable poly (L-lactic acid) matrices for the sustained delivery of the antisense oligonucleotides. Journal of Controlled Release 37:173–183.
   Google Scholar
• Lewis KJ, Irwin WJ, Akhtar S. 1998. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: Characterization of P(LA-GA) copolymer microspheres in vitro. Journal of Drug Targeting 5:291–302.
   PubMedGoogle Scholar
• Monyer H, Sprengel H, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeburg PH. 1992. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science 256:1217–1221.
   PubMedGoogle Scholar
• Pardridge WM. 1997. Drug delivery to the brain. Journal of Cerebral Blood Flow and Metabolism 17:713-731. Pardridge WM. 2001. Drug targeting, drug discovery and brain drug development. In: Pardridge WM, editor. Brain drug targeting. Cambridge: Cambridge University Press.
   Google Scholar
• Quintanar-Guerrero D, Fessi H, Allémann E, Dolker E. 1996. Influence of stabilizing agents and preparative variables on the formation of poly(D,L-lactic acid) nanoparticles by an emulsification-diffusion technique. International Journal of Pharmaceutics 143:133–141.
   Google Scholar
• Schwab G, Chavany C, Doroux I, Goubins G, Lebeau J, Helene C. 1994. Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit matted ha-ras-mediated cell proliferation and tumorigenicity in nude mice. Proceedings of the National Academy of Sciences (USA) 91:10460–10464.
   PubMedGoogle Scholar
• Sze SCW, Wong CKC, Yung KKL. 2001. Modulation of the gene expression of N-methyl-D-aspartate receptor NR2B subunit in the rat neostriatum by a single dose specific antisense oligodeoxynucleotide. Neurochemistry International 39:319–327.
   PubMedGoogle Scholar
• Whitesell L, Geselowitz D, Chavany C, Fahmy B, Walbridge S, Alger Jr, Neckers L. 1993. Stability, clearence and disposition of intraventriculary administered oligodeoxynucleotides: Implications for therapeutic application within the central nervous system. Proceedings of the National Academy of Sciences (USA) 90:4665–4669.
   PubMedGoogle Scholar
• Zhu X, Lu L, Currier BL, Windebank AJ, Yaszemski MJ. 2002. Controlled release of NFKB decoy oligonucleotides from biodegradable polymer microparticles. Biomaterials 23:2683–2692.
   PubMedGoogle Scholar
• Zimmer A. 1999. Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers. Methods 18:286–295.
   PubMedGoogle Scholar